Superior Diagnostic Imaging Without the Risk

Partner News | Published: Monday, February 14, 2022 3:00 pm

by CDL Nuclear Technologies / CardioNavix

PET/CT is one of the most advanced molecular imaging diagnostic tools globally. PET (Positron Emission Tomography) is utilized along with anatomical CT (Computed Tomography) for an enhanced hybrid imaging process. Cardiologists can use this innovative advanced imaging modality to measure cardiac perfusion while simultaneously assessing coronary anatomy within a single scan session lasting less than 45 minutes.

With a PET/CT scan, patients with suspected coronary artery disease can receive valuable corresponding information that could help guide clinical patient management. 


In a study of 15 cardiac SPECT and PET studies, researchers concluded that PET outperformed SPECT on both sensitivity and specificity (90 percent vs. 85 percent) and specificity (88 percent vs. 85 percent). According to another study, invasive coronary arteriography and coronary artery bypass graft surgery rates were reduced by 50% in patients with intermediate pre-test likelihood of coronary artery disease using cardiac PET. 

Thus, cardiovascular disease can now be evaluated more rapidly and more accurately while delivering lower radiation levels to patients.

By taking images of high resolution and clarity, a cardiac PET scan can provide accurate measurements of blood flow between coronary arteries and heart muscle as well as detect dead or injured tissue.  A PET scan can give cardiologists a clear indication of whether a patient might benefit from surgery, for example, when a patient has coronary artery disease (CAD) or tissue damage following a heart attack. 


PET is economically beneficial in that it is not only useful for patients but can also generate revenue for your organization. For practices contemplating cardiovascular PET, PET/CT, volumes of patients will be a helpful indicator. Even though there is no sure way of knowing, your cardiac PET program should serve at least eight patients a day-if not more-to compensate for SPECT attrition.  Additionally, utilization of the cath lab is much improved for patients and providers following results that a higher percentage of patients underwent coronary angiography, had high-grade obstructive CAD, had left main or severe 3-vessel disease, and had coronary revascularization after a PET scan versus SPECT scan.


If your practice is looking to upgrade to the Gold Standard of molecular imaging (PET/CT) consider partnering with CDL Nuclear Technologies, the largest and most trusted turn-key Cardiac PET & PET/CT provider in the nation. With our customizable solutions and expertise in the delivery of advanced cardiovascular imaging and regulatory compliance, we ensure the highest quality of on-site cardiac PET programs available, along with unmatched affordability. 

The CDL low-risk business model guides your practice through:

  • Assessment and Consultation
  • Planning and Construction
  • Training for Physicians and Staff
  • Billing Assistance
  • Customized Marketing
  • Accreditation Processes
  • Operational Support
  • Maintenance and Repairs
Looking for a program more adapted to your existing PET program?  Consider the convenience of mobility.  With CardioNavix, the subsidiary of CDL Nuclear Technologies, we can provide mobile radioisotope, removing the need for a fixed Rb-82 generator.  This flexibility allows hospitals and clinics to match their supply to their individual camera availability and patient volume, so you only pay for the number of isotope doses you need.

CardioNavix program is ideal for:

  • Healthcare providers imaging on a part-time schedule
  • Patient care sites located in less populous areas
  • Healthcare sites attempting to scale and grow into a full-time imaging program


CDL Nuclear Technologies & CardioNavix will be attending MedAxiom’s CV Transforum Spring ‘22 Conference in Atlanta, GA April 21st-23rd. Stop by our booth to speak to one of our representatives regarding our streamlined programs that allow your practice to have no upfront cost and 100% revenue on your very first patient!

To learn more about CDL Nuclear Technologies and CardioNavix, visit us at and If you would like to receive more information submit a contact form from our websites and one of our representatives will be in touch with you to discuss in more detail.





Knaapen, P., de Haan, S., Hoekstra, O. S., Halbmeijer, R., Appelman, Y. E., Groothuis, J. G., Comans, E. F., Meijerink, M. R., Lammertsma, A. A., Lubberink, M., Götte, M. J., & van Rossum, A. C. (2010). Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 18(2), 90–98.

Knight, S., Min, D. B., Le, V. T., Meredith, K. G., Dhar, R., Biswas, S., Jensen, K. R., Mason, S. M., Ethington, J. D., Lappe, D. L., Muhlestein, J. B., Anderson, J. L., & Knowlton, K. U. (2018). Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era. JCI insight, 3(9), e120949.

This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.